703 related articles for article (PubMed ID: 27609895)
1. Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers.
Mayers JR; Torrence ME; Danai LV; Papagiannakopoulos T; Davidson SM; Bauer MR; Lau AN; Ji BW; Dixit PD; Hosios AM; Muir A; Chin CR; Freinkman E; Jacks T; Wolpin BM; Vitkup D; Vander Heiden MG
Science; 2016 Sep; 353(6304):1161-5. PubMed ID: 27609895
[TBL] [Abstract][Full Text] [Related]
2. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
[TBL] [Abstract][Full Text] [Related]
3. Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours.
Zhu Z; Achreja A; Meurs N; Animasahun O; Owen S; Mittal A; Parikh P; Lo TW; Franco-Barraza J; Shi J; Gunchick V; Sherman MH; Cukierman E; Pickering AM; Maitra A; Sahai V; Morgan MA; Nagrath S; Lawrence TS; Nagrath D
Nat Metab; 2020 Aug; 2(8):775-792. PubMed ID: 32694827
[TBL] [Abstract][Full Text] [Related]
4. GEO data mining and TCGA analysis reveal altered branched chain amino acid metabolism in pancreatic cancer patients.
Li JY; Sun F; Yang CL; Zhou HF; Gao M; Zhang Q; Chen H; Zhou P; Xiao J; Fan H
Aging (Albany NY); 2021 Apr; 13(8):11907-11918. PubMed ID: 33882453
[TBL] [Abstract][Full Text] [Related]
5. Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism.
Lee JH; Cho YR; Kim JH; Kim J; Nam HY; Kim SW; Son J
Exp Mol Med; 2019 Nov; 51(11):1-11. PubMed ID: 31784505
[TBL] [Abstract][Full Text] [Related]
6. Acetylation promotes BCAT2 degradation to suppress BCAA catabolism and pancreatic cancer growth.
Lei MZ; Li XX; Zhang Y; Li JT; Zhang F; Wang YP; Yin M; Qu J; Lei QY
Signal Transduct Target Ther; 2020 May; 5(1):70. PubMed ID: 32467562
[TBL] [Abstract][Full Text] [Related]
7. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
8. Targeting metabolic reprogramming in KRAS-driven cancers.
Kawada K; Toda K; Sakai Y
Int J Clin Oncol; 2017 Aug; 22(4):651-659. PubMed ID: 28647837
[TBL] [Abstract][Full Text] [Related]
9. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer.
Dey P; Baddour J; Muller F; Wu CC; Wang H; Liao WT; Lan Z; Chen A; Gutschner T; Kang Y; Fleming J; Satani N; Zhao D; Achreja A; Yang L; Lee J; Chang E; Genovese G; Viale A; Ying H; Draetta G; Maitra A; Wang YA; Nagrath D; DePinho RA
Nature; 2017 Feb; 542(7639):119-123. PubMed ID: 28099419
[TBL] [Abstract][Full Text] [Related]
10. Branched-chain amino acid metabolism in cancer.
Ananieva EA; Wilkinson AC
Curr Opin Clin Nutr Metab Care; 2018 Jan; 21(1):64-70. PubMed ID: 29211698
[TBL] [Abstract][Full Text] [Related]
11. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
12. Hypervalinemia and hyperleucine-isoleucinemia caused by mutations in the branched-chain-amino-acid aminotransferase gene.
Wang XL; Li CJ; Xing Y; Yang YH; Jia JP
J Inherit Metab Dis; 2015 Sep; 38(5):855-61. PubMed ID: 25653144
[TBL] [Abstract][Full Text] [Related]
13. Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment.
Kerk SA; Papagiannakopoulos T; Shah YM; Lyssiotis CA
Nat Rev Cancer; 2021 Aug; 21(8):510-525. PubMed ID: 34244683
[TBL] [Abstract][Full Text] [Related]
14. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE
Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980
[TBL] [Abstract][Full Text] [Related]
15. Expanding the genetic and phenotypic spectrum of branched-chain amino acid transferase 2 deficiency.
Knerr I; Colombo R; Urquhart J; Morais A; Merinero B; Oyarzabal A; Pérez B; Jones SA; Perveen R; Preece MA; Rogers Y; Treacy EP; Mayne P; Zampino G; MacKinnon S; Wassmer E; Yue WW; Robinson I; Rodríguez-Pombo P; Olpin SE; Banka S
J Inherit Metab Dis; 2019 Sep; 42(5):809-817. PubMed ID: 31177572
[TBL] [Abstract][Full Text] [Related]
16. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.
Zhang L; Han J
Biochem Biophys Res Commun; 2017 Apr; 486(2):224-231. PubMed ID: 28235484
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development.
Kang ZR; Jiang S; Han JX; Gao Y; Xie Y; Chen J; Liu Q; Yu J; Zhao X; Hong J; Chen H; Chen YX; Chen H; Fang JY
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166941. PubMed ID: 37926361
[TBL] [Abstract][Full Text] [Related]
18. The KRAS-BCAA-BCAT2 axis in PDAC development.
Falcone M; Maddocks ODK
Nat Cell Biol; 2020 Feb; 22(2):139-140. PubMed ID: 32029895
[No Abstract] [Full Text] [Related]
19. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Zhang S; Chung WC; Xu K
Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
[TBL] [Abstract][Full Text] [Related]
20. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
